| [1] |
Puschhof J, Pleguezuelos-Manzano C, Clevers H. Organoids and organs-on-chips: insights into human gut-microbe interactions[J]. Cell Host Microbe, 2021, 29(6): 867-878.
|
| [2] |
Abdullah KG, Bird CE, Buehler JD, et al. Establishment of patient-derived organoid models of lower-grade glioma[J]. Neuro Oncol, 2022, 24(4): 612-623.
|
| [3] |
Wang HM, Zhang CY, Peng KC, et al. Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study[J]. Cell Rep Med, 2023, 4(2): 100911.
|
| [4] |
Beumer J, Puschhof J, Bauzá-Martinez J, et al. High-resolution mRNA and secretome Atlas of human enteroendocrine cells[J]. Cell, 2020,182(4): 1062-1064.
|
| [5] |
Ackermann M, Rafiei Hashtchin A, Manstein F, et al. Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors[J]. Nat Protoc, 2022, 17(2): 513-539.
|
| [6] |
Roberts TG Jr, Goulart BH, Squitieri L, et al. Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials[J]. JAMA, 2004, 292(17): 2130-2140.
|
| [7] |
Leslie JL, Huang S, Opp JS, et al. Persistence and toxin production by clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function[J]. Infect Immun, 2015, 83(1): 138-145.
|
| [8] |
Williamson IA, Arnold JW, Samsa LA, et al. A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology[J]. Cell Mol Gastroenterol Hepatol, 2018, 6(3): 301-319.
|
| [9] |
Spence JR, Mayhew CN, Rankin SA, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro[J]. Nature, 2011, 470(7332): 105-109.
|
| [10] |
Forbester JL, Goulding D, Vallier L, et al. Interaction of salmonella enterica serovar typhimurium with intestinal organoids derived from human induced pluripotent stem cells[J]. Infect Immun, 2015, 83(7): 2926-2934.
|
| [11] |
Zheng L, Kelly CJ, Colgan SP. Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A review in the theme: cellular responses to hypoxia[J]. Am J Physiol Cell Physiol, 2015, 309(6): C350-C360.
|
| [12] |
Ranganathan S, Doucet M, Grassel CL, et al. Evaluating shigella flexneri pathogenesis in the human enteroid model[J]. Infect Immun, 2019, 87(4): e00740-18.
|
| [13] |
Koestler BJ, Ward CM, Fisher CR, et al. Human intestinal enteroids as a model system of shigella pathogenesis[J]. Infect Immun, 2019, 87(4): e00733-18.
|
| [14] |
Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, et al. Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli[J]. Nature, 2020, 580(7802): 269-273.
|
| [15] |
Chang-Graham AL, Perry JL, Engevik MA, et al. Rotavirus induces intercellular calcium waves through ADP signaling[J]. Science, 2020, 370(6519): eabc3621.
|
| [16] |
Kayisoglu O, Weiss F, Niklas C, et al. Location-specific cell identity rather than exposure to GI microbiota defines many innate immune signalling cascades in the gut epithelium[J]. Gut, 2021, 70(4): 687-697.
|
| [17] |
Naumovska E, Aalderink G, Wong VC, et al. Direct on-chip differentiation of intestinal tubules from induced pluripotent stem cells[J]. Int J Mol Sci, 2020, 21(14): 4964.
|
| [18] |
Badgeley A, Anwar H, Modi K, et al. Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives[J]. Biochim Biophys Acta Rev Cancer, 2021,1875(1): 188494.
|
| [19] |
Xiong L, Wang S, Dean JW, et al. Group 3 innate lymphoid cell pyroptosis represents a host defence mechanism against Salmonella infection[J]. Nat Microbiol, 2022, 7(7): 1087-1099.
|
| [20] |
Lu X, Xie S, Ye L, et al. Lactobacillus protects against S. Typhimurium-induced intestinal inflammation by determining the fate of epithelial proliferation and differentiation[J]. Mol Nutr Food Res, 2020, 64(5): e1900655.
|
| [21] |
Glassner KL, Abraham BP, Quigley E. The microbiome and inflammatory bowel disease[J]. J Allergy Clin Immunol, 2020, 145(1): 16-27.
|
| [22] |
Fong W, Li Q, Yu J. Gut microbiota modulation: A novel strategy for prevention and treatment of colorectal cancer[J]. Oncogene, 2020, 39(26): 4925-4943.
|
| [23] |
van der Vaart J, Bosmans L, Sijbesma SF, et al. Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves’ hyperthyroidism[J]. Proc Natl Acad Sci U S A, 2021, 118(51): e2117017118.
|